Cargando…
New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to a paradigm shift in healthcare worldwide. Little is known about the impact on the cardiovascular system, and the incidence and consequences of new onset of atrial fibrillation (AF) in infected patients remai...
Autores principales: | Sanz, Ana Pardo, Tahoces, Luisa Salido, Pérez, Rodrigo Ortega, Ferrer, Eduardo González, Recalde, Ángel Sánchez, Gómez, José Luis Zamorano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105065/ https://www.ncbi.nlm.nih.gov/pubmed/33140386 http://dx.doi.org/10.5603/CJ.a2020.0145 |
Ejemplares similares
-
Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021) -
COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm
por: Bell, Max, et al.
Publicado: (2023) -
Remote proctoring for cryoballoon ablation of atrial fibrillation: A challenge or an opportunity in the COVID-19 era?
por: Glowniak, Andrzej, et al.
Publicado: (2021) -
Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021) -
CRT-200.08 In-Hospital Outcomes of Atrial Fibrillation in COVID-19 Hospitalizations: An Insight From the National Inpatient Sample Database
por: Goni, Thatiana Schulze, et al.
Publicado: (2023)